Development and validation of a 21-gene prognostic signature in neuroblastoma

Survival outcomes for patients with neuroblastoma vary markedly and reliable prognostic markers and risk stratification tools are lacking. We sought to identify and validate a transcriptomic signature capable of predicting risk of mortality in patients with neuroblastoma. The TARGET NBL dataset (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Mehul, Kannappan, Sunand, Jain, Mohit, Douglass, David, Shah, Ravi, Bose, Pinaki, Narendran, Aru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397261/
https://www.ncbi.nlm.nih.gov/pubmed/37532697
http://dx.doi.org/10.1038/s41598-023-37714-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397261/
https://www.ncbi.nlm.nih.gov/pubmed/37532697
http://dx.doi.org/10.1038/s41598-023-37714-9

Ejemplares similares